COLLEEN ADLER: Open Payments
NPI 1346913746 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 29 payments from 17 companies in 2025. Trend: 2023 $144 · 2024 $0 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $129 |
| ABBVIE INC. | 2 | $47 |
| Lilly USA, LLC | 2 | $38 |
| IBSA Pharma Inc. | 2 | $36 |
| Corcept Therapeutics | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| PFIZER INC. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| KYOWA KIRIN, INC. | 1 | $27 |
Products named: Ozempic, QULIPTA, Wegovy, Tirosint, Korlym, REZDIFFRA, TRELEGY ELLIPTA, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
